P-1874. Impact of Compromised Host AntimicRobial Management Service (CHARMS) on All Cause Readmission in Solid Organ Transplant Patients Discharged on Intravenous Antimicrobials
Brent Footer(University of North Carolina at Chapel Hill), David van Duin(University of North Carolina at Chapel Hill), Tessa M. Andermann(University of North Carolina at Chapel Hill), Anne Friedland(University of North Carolina at Chapel Hill), Luther A. Bartelt(University of North Carolina at Chapel Hill), Elizabeth C Arant(University of North Carolina at Chapel Hill), Zack Deyo(University of North Carolina at Chapel Hill), Arlene C. Seña(University of North Carolina at Chapel Hill), Mary Catherine Bowman(University of North Carolina at Chapel Hill), Anne M. Lachiewicz(University of North Carolina at Chapel Hill)
Cited by 0
Related Papers
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study
|The Lancet Infectious Diseases|2021|338
Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study
|The Lancet Infectious Diseases|2020|328
Risk of Breakthrough SARS-CoV-2 Infections in Adult Transplant Recipients
|Transplantation|2021|162
Molecular Testing for Trichomonas vaginalis in Women: Results from a Prospective U.S. Clinical Trial
|Journal of Clinical Microbiology|2011|152